This lecture delves into the concept of personalized medicine, focusing on genetic variability and its impact on drug response. It covers topics such as mutations, SNP, CNV, and GWAS, explaining how these factors influence the efficacy and safety of pharmaceutical treatments. The lecture also explores the interplay between metabolomics, drugs, and genetics, highlighting the potential of tailoring medications to individual patients based on their genetic and metabolic profiles.